| scholarly article | Q13442814 |
| P50 | author | Kandasamy Eniyan | Q56951285 |
| Andrej Perdih | Q56951306 | ||
| P2093 | author name string | Urmi Bajpai | |
| Geetha Vani Rayasam | |||
| Anuradha Kumar | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Crystal Structures of Active Fully Assembled Substrate- and Product-Bound Complexes of UDP-N-Acetylmuramic Acid:L-Alanine Ligase (MurC) from Haemophilus influenzae | Q27641592 | ||
| ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation | Q27658363 | ||
| Essential residues for the enzyme activity of ATP-dependent MurE ligase from Mycobacterium tuberculosis | Q27666292 | ||
| Functional Consequence of Covalent Reaction of Phosphoenolpyruvate with UDP-N-acetylglucosamine 1-Carboxyvinyltransferase (MurA) | Q27677546 | ||
| A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays | Q28145712 | ||
| Recent advances in the formation of the bacterial peptidoglycan monomer unit | Q28204307 | ||
| Kinetic mechanism and inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by the antibiotic D-cycloserine | Q28282522 | ||
| Comparison of the UDP-N-acetylmuramate:L-alanine ligase enzymes from Mycobacterium tuberculosis and Mycobacterium leprae | Q28487429 | ||
| Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis | Q28488668 | ||
| Multidrug-resistant tuberculosis. | Q30344085 | ||
| MurD ligase from E. coli: Tetrahedral intermediate formation study by hybrid quantum mechanical/molecular mechanical replica path method. | Q31171716 | ||
| A high-throughput screening fluorescence polarization assay for fatty acid adenylating enzymes in Mycobacterium tuberculosis | Q33965669 | ||
| 3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria | Q34352165 | ||
| Antibiotic resistance-the need for global solutions | Q34386251 | ||
| Bacterial cell wall synthesis: new insights from localization studies | Q34474627 | ||
| Structure, function and dynamics in the mur family of bacterial cell wall ligases | Q34560768 | ||
| Cytoplasmic steps of peptidoglycan synthesis in Escherichia coli | Q36389164 | ||
| Novel targets for tuberculosis drug discovery | Q36563853 | ||
| Multi-targeting by monotherapeutic antibacterials. | Q36679193 | ||
| Cytoplasmic steps of peptidoglycan biosynthesis | Q37081699 | ||
| Cell-division inhibitors: new insights for future antibiotics | Q37103616 | ||
| DD-ligases as a potential target for antibiotics: past, present and future. | Q37550718 | ||
| Bacterial cell wall assembly: still an attractive antibacterial target | Q37828273 | ||
| Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F. | Q38206339 | ||
| The biology of Mur ligases as an antibacterial target | Q38240597 | ||
| Biochemical characterization of a phosphinate inhibitor of Escherichia coli MurC. | Q38296349 | ||
| Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis | Q38429617 | ||
| Synthesis and antibacterial evaluation of a new series of N-Alkyl-2-alkynyl/(E)-alkenyl-4-(1H)-quinolones | Q39317454 | ||
| Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF): experimental and computational characterization | Q41103702 | ||
| mMass data miner: an open source alternative for mass spectrometric data analysis | Q42646051 | ||
| Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis. | Q42933739 | ||
| Purification and biochemical characterization of Mur ligases from Staphylococcus aureus | Q42957776 | ||
| Multi-targeted therapy for leprosy: insilico strategy to overcome multi drug resistance and to improve therapeutic efficacy | Q44930444 | ||
| UDP-N-acetylmuramic acid (UDP-MurNAc) is a potent inhibitor of MurA (enolpyruvyl-UDP-GlcNAc synthase). | Q45307734 | ||
| Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach | Q46049944 | ||
| Characterization of mycobacterial UDP-N-acetylglucosamine enolpyruvyle transferase (MurA). | Q46941447 | ||
| The mycobacterial cell wall: structure, biosynthesis and sites of drug action. | Q47829728 | ||
| Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis | Q47904411 | ||
| Kinetic mechanism of the Escherichia coli UDPMurNAc-tripeptide D-alanyl-D-alanine-adding enzyme: use of a glutathione S-transferase fusion | Q48056619 | ||
| Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. | Q50771317 | ||
| Evaluation of the kinetic mechanism of Escherichia coli uridine diphosphate-N-acetylmuramate:L-alanine ligase. | Q52262082 | ||
| Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF). | Q52876027 | ||
| Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway. | Q52895876 | ||
| Design of inhibitors of the MurF enzyme of Streptococcus pneumoniae using docking, 3D-QSAR, and de Novo design. | Q53751485 | ||
| Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
| MurD enzymes from different bacteria: Evaluation of inhibitors | Q57998775 | ||
| 5-Benzylidenethiazolidin-4-ones as Multitarget Inhibitors of Bacterial Mur Ligases | Q58216000 | ||
| In vitro reconstruction of the biosynthetic pathway of peptidoglycan cytoplasmic precursor in Pseudomonas aeruginosa | Q74257167 | ||
| Phosphinate Inhibitors of the D-Glutamic Acid-Adding Enzyme of Peptidoglycan Biosynthesis | Q74822592 | ||
| Homology modeling and docking analyses of M. leprae Mur ligases reveals the common binding residues for structure based drug designing to eradicate leprosy | Q82603395 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 35134 | |
| P577 | publication date | 2016-10-13 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis | |
| P478 | volume | 6 |
| Q92647920 | Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen |
| Q55091455 | Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains. |
| Q57470806 | Reaching toward underexplored targets in antibacterial drug design |
Search more.